SCHEMBL6947632

SCHEMBL6947632

CSc1nc(OCC(F)(F)F)c(C#N)c(N2CCc3ccccc3CC2)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 1/20 0.39
KDM4E B2RXH2 10/20 0.39
ALDH1A1 P00352 10/20 0.39
HPGD P15428 5/20 0.39
MAPT P10636 4/20 0.39
MEN1 O00255 4/20 0.39
HTT P42858 4/20 0.39
KMT2A Q03164 4/20 0.39
HSD17B10 Q99714 4/20 0.39
TP53 P04637 1/20 0.39
SQOR Q9Y6N5 1/20 0.35
L3MBTL1 Q9Y468 3/20 0.35
TDP1 Q9NUW8 3/20 0.35
MAPK1 P28482 3/20 0.35
LMNA P02545 4/20 0.34
NPSR1 Q6W5P4 2/20 0.34
POLB P06746 1/20 0.34
RAB9A P51151 1/20 0.34
GAA P10253 1/20 0.34
TSHR P16473 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6956303 0.86 KDM4E (0.41) PIK3CDKDM4EALDH1A1HPGDMAPT
SCHEMBL6949790 0.85 ALDH1A1 (0.41) KDM4EALDH1A1HPGDMAPTMEN1
SCHEMBL4420371 0.85 GRM2 (0.45) PIK3CD
SCHEMBL6957307 0.85 LMNA (0.44) PIK3CDKDM4EALDH1A1HPGDMAPT
SCHEMBL6955735 0.84 ADRA2A (0.38) KDM4EALDH1A1HPGDMAPTMEN1
SCHEMBL6945764 0.84 PIK3CD (0.37) PIK3CDKDM4EALDH1A1HPGDMAPT
SCHEMBL6950069 0.84 KDM4E (0.42) PIK3CDKDM4EALDH1A1HPGDMAPT
SCHEMBL6953029 0.83 GRM2 (0.40) KDM4EALDH1A1HPGDMAPTMEN1
SCHEMBL6955400 0.82 PIK3CD (0.38) PIK3CDKDM4EALDH1A1HPGDMAPT
SCHEMBL6948239 0.82 PIK3CD (0.39) PIK3CDKDM4EALDH1A1HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074549-B1 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors HOFFMANN LA ROCHE (CH) 2003-11-19 EP disclosed
US-6218385-B1 FOR THERAPY OR PROPHYLAXIS OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS SUCH AS EPILEPSY, STROKE, CHRONIC AND ACUTE PAIN, PSYCHOSIS, SCHIZOPHRENIA, ALZHEIMER'S DISEASE, COGNITIVE DISORDERS AND MEMORY DEFICITS HOFFMANN-LA ROCHE INC. 2001-04-17 US disclosed
EP-1074549-A2 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors F. HOFFMANN-LA ROCHE AG (CH) 2001-02-07 EP disclosed